Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Receivables (2016 - 2026)

Cryo Cell International's Receivables history spans 17 years, with the latest figure at $7.7 million for Q1 2026.

  • Quarterly results put Receivables at $7.7 million for Q1 2026, down 3.97% from a year ago — trailing twelve months through Feb 2026 was $7.7 million (down 3.97% YoY), and the annual figure for FY2025 was $7.7 million, down 4.74%.
  • Receivables for Q1 2026 was $7.7 million at Cryo Cell International, roughly flat from $7.7 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $15.3 million in Q3 2022 to a low of $6.7 million in Q4 2022.
  • The 5-year median for Receivables is $7.7 million (2025), against an average of $8.9 million.
  • The sharpest move saw Receivables surged 174.68% in 2022, then tumbled 53.65% in 2023.
  • Year by year, Receivables stood at $6.7 million in 2022, then grew by 9.2% to $7.3 million in 2023, then grew by 11.17% to $8.1 million in 2024, then decreased by 4.74% to $7.7 million in 2025, then fell by 0.14% to $7.7 million in 2026.
  • According to Business Quant data, Receivables over the past three periods came in at $7.7 million, $7.7 million, and $7.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.